Publications

Filter by type

Filter by year

2024

Effectiveness of tildrakizumab for itch, pain, and fatigue in patients with moderate-to-severe psoriasis: 52-week results from the real-world POSITIVE study

U. Mrowietz, M. Augustin, Z. Reguiai, S. Gerdes, E. Daudén, W. Weger, J.T. Maul, P. Laws, L. Naldi, P.D. Ghislain, E. de Jong, S. Mburu, V. Koscielny, E. Massana, I. Kasujee & R. Sommer

Poster presented at the 33rd EADV Congress, Amsterdam, the Netherlands

Effectiveness of tildrakizumab in patients with moderate-to-severe psoriasis located in special areas: 52-week results from the POSITIVE study

M. Augustin, R. Sommer, Z. Reguiai, S. Gerdes, E. Daudén, W. Weger, J.T. Maul, P. Laws, L. Naldi, P.D. Ghislain, E. de Jong, S. Mburu, V. Koscielny, E. Massana, I. Kasujee & U. Mrowietz

Poster presented at the 33rd EADV Congress, Amsterdam, the Netherlands

Assessing Quality of Life in Children with Dermatological Conditions – Validation of the InToDermQoL Questionnaire

J. Traxler, M. Augustin, H. Ott, S. Hoffmann, R. Fölster-Holst, M. Baumeister, P. Staubach-Renz, N. da Silva-Burger & R. Sommer

Oral presentation presented at the 23rd DKVF Conference, Potsdam, Germany

Vitiligo - a disease: A position paper on stigmatization, life quality impairment and psychosocial comorbidity

M. Böhm, R. Sommer, U. Gieler, P. Staubach, A. Zink, C. Apfelbacher & E.M.J. Peters

Vitiligo is a common disorder characterized by the visible loss of skin pigmentation. Non-segmental vitiligo (NSV) is the major subtype. The disease is caused by autoimmune-mediated destruction of melanocytes. Vitiligo leads to stigmatization and a significant reduction in quality of life. We recommend optimizing care by incorporating the assessment of quality of life as a standard in routine care, in addition to monitoring disease activity.

Patient needs in women of childbearing age with psoriasis: retrospective analysis from the German PsoBest registry

N. da Silva-Burger, M. Augustin, L. Westphal, L. Kühl, B. Stephan & R. Sommer

Women of childbearing age (WoCBA) with psoriasis face additional burden related to contraindications of systemic treatments during pregnancy/lactation and to the physical and psychosocial impact of psoriasis on their intimate/sexual relationships.

Within a people-centered health care model, this study aimed to identify specific patient needs and their correlates in WoCBA (18–45 years), in comparison to same-age men and women above 45 years.

Breaking Barriers: Randomized Controlled Trials Assessing an Intervention to Combat Stigma in Chronic Skin Disease

J. Traxler, C.C. Braren-von Stülpnagel, M. Augustin, M. Grosser & R. Sommer

Oral presentation presented at the 10th Appearance Matters Conference, Bristol, UK

Personal, Financial and Time Burden in Inherited Ichthyoses: A Survey of 144 Patients in a University-based Setting

C. Klein, V. Oji, R. Sommer, M. Augustin, S. Ständer, S. Salzmann, K. Kiekbusch, J. Bodes, M. F. Danzer, H. Traupe, J. Fischer, S. Steinke & K. Süßmuth

We investigated costs, time and disease burden of ichthyoses. The study addresses difficulties of the healthcare situation for patients with ichthyoses and reveals potential improvements.

Unterdiagnostiziert und unterbehandelt

S. Schmotz, L. N. Hoyer, M. Augustin, R. Sommer, J. Traxler & S. Moritz

Certified CME training by the German Academy of Dermatology.


Dermatillomania requires specialist knowledge, a correct diagnosis and a lot of time for sensitive and differentiated exploration by the practitioner. According to current research, the treatment of choice is cognitive behavioural therapy, in particular habit reversal training.

Reducing self-stigma in chronic skin disease - Development and pilot-test of the HautKompass online programme

J. Traxler, C.F.Z. Stuhlmann, N. da Silva-Burger, C. Stierle, M. Rudnik & R. Sommer

Oral presentation presented at the European Health Psychology Society Conference (EHPS), Cascais, Portugal

Impact of patient psoriasis on partner well-being in a real-world setting: 52-week interim data of the phase IV POSITIVE study

U. Mrowietz, R. Sommer, Z. Reguiai, S. Gerdes, E. Daudén, W. Weger, J.T. Maul, P. Laws, L. Naldi, P.D. Ghislain, E. de Jong, S. Mburu, V. Koscielny, E. Massana, I. Kasujee & M. Augustin

Poster presented at the 33rd EADV Congress, Amsterdam, the Netherlands